Kestrel Group Reports Second Quarter 2026 Financial Results

Go back to Kestrel Group Reports Second Quarter 2026 Financial Results
KING PHARMACEUTICALS (NASDAQ: KG) Delayed: 4.91 -0.33 (6.3%)
Previous Close $5.24    52 Week High $14.26 
Open $5.15    52 Week Low $7.18 
Day High $5.15    P/E 14.44 
Day Low $4.81    EPS $0.34 
Volume 12,795